MarketPulse

material misrepresentation

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

NuScale Power Stock Plummets 12.4% Over $495M ENTRA1 Deal; Securities Fraud Lawsuit Filed

NuScale Power faces securities fraud lawsuit after disclosing $495M payment to inexperienced nuclear startup ENTRA1 Energy, triggering 12.4% stock decline.
SMRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

Biogen Class Action Certified: Securities Lawsuit Over 2021 Misrepresentation Claims

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.
BIIBclass actionfederal securities laws
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

NuScale's $495M ENTRA1 Deal Sparks Securities Fraud Lawsuit Over Undisclosed Risks

NuScale Power faces class action lawsuit after paying $495M to inexperienced nuclear startup ENTRA1, triggering 12.4% stock plunge and investor claims of material risk concealment.
SMRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Mereo BioPharma Faces Securities Litigation Over Clinical Trial Disclosures

Mereo BioPharma faces securities lawsuit alleging misrepresentations about Phase 3 trial results for setrusumab, causing investor losses.
SNOWMREOsecurities fraudsecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Class Action Lawsuit Filed Against REGENXBIO Over Gene Therapy Safety Disclosures

Law firm sues REGENXBIO for allegedly hiding safety concerns about gene therapy RGX-111. Stock dropped 17.8% after FDA clinical hold due to tumor in trial participant.
RGNXsecurities fraudclass action lawsuit